Whittier Trust Co. of Nevada Inc. Acquires 768 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,574 shares of the medical equipment provider's stock after buying an additional 768 shares during the period. Whittier Trust Co. of Nevada Inc.'s holdings in Intuitive Surgical were worth $17,123,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. Geode Capital Management LLC increased its holdings in Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after buying an additional 243,802 shares in the last quarter. Norges Bank purchased a new position in Intuitive Surgical in the fourth quarter valued at $2,401,493,000. Invesco Ltd. increased its holdings in Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after buying an additional 295,025 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after buying an additional 494,496 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.1%

Shares of Intuitive Surgical stock traded up $0.41 during trading hours on Wednesday, hitting $512.64. The company's stock had a trading volume of 1,863,510 shares, compared to its average volume of 1,685,803. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The business has a fifty day moving average of $536.71 and a 200 day moving average of $536.21. The company has a market capitalization of $183.74 billion, a PE ratio of 75.17, a P/E/G ratio of 5.43 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the firm posted $1.50 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. Barclays cut their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Citigroup reissued a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $592.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.